Biological research on drug abuse and addiction in Hispanics: Current status and future directions

Drug and Alcohol Dependence

Volumn 84, Issue SUPPL., 2006, Pages

  Trujillo, Keith A ^a   Castañeda, Edward ^b   Martínez, Diana ^c   González, Gerardo ^d  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ethnicity; Hispanics; Neurobiology

Indexed keywords

BUPRENORPHINE; METHADONE; NICOTINE PATCH;

ARTICLE; BIOLOGY; DRUG ABUSE; DRUG DEPENDENCE; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENETICS; HISPANIC; HUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; RESEARCH; UNITED STATES;

ALDEHYDE DEHYDROGENASE; BIOLOGY; BRAIN; CARCINOGENS, ENVIRONMENTAL; DOPAMINE; ENVIRONMENT; FORECASTING; GENE EXPRESSION; HISPANIC AMERICANS; HUMANS; N-METHYLASPARTATE; NOREPINEPHRINE; NUTRITIONAL STATUS; PREVALENCE; RECEPTORS, GABA-A; RESEARCH; SEROTONIN; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

ANIMALIA;

EID: 33746543687     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.05.004     Document Type: Article

References (131)

1. Adams W.R., Kiefer S.W., and Badia-Elder N. Tryptophan deficiency and alcohol consumption in rats as a model for disadvantaged human populations: a preliminary study. Med. Anthropol. 16 (1995) 175-191
2. Amaro H., and Zambrana R.E. Criollo, Mestizo, Mulato, LatiNegro, Indigena, White or Black? The US Hispanic/Latino population and multiple responses in the 2000 census. Am. J. Public Health 90 (2000) 1724-1727
3. Anderson N.B., and Nickerson K.J. Genes, race, and psychology in the genome era. Am. Psychol. 60 (2005) 5-8
4. Bauer L.O. Differential effects of alcohol, cocaine, and opioid abuse on event-related potentials recorded during a response competition task. Drug Alcohol Depend. 66 (2002) 137-145
5. Bellivier F. Genetic association studies: definition of cases and controls. In: Leboyer M., and Bellivier F. (Eds). Psychiatric Genetics: Methods and Reviews (2003), Humana Press, Totowa, NJ 127-141
6. Benowitz N.L., Perez-Stable E.J., Herrera B., and Jacob III P. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J. Natl. Cancer Inst. 94 (2002) 108-115
7. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., Tischfield J.A., Kreek M.J., and Yu L. Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl. Acad. Sci. U.S.A. 98 (1998) 9608-9613
8. Bradman M.A., Harnly M.E., Draper W., Seidel S., Teran S., Wakeham D., and Neutra R. Pesticide exposures to children from California's Central Valley: results of a pilot study. J. Expo. Anal. Environ. Epidemiol. 7 (1997) 217-234
9. Burchard E.G., Ziv E., Coyle N., Gomez S.L., Tang H., Karter A.J., Mountain J.L., Perez-Stable E.J., Sheppard D., and Risch N. The importance of race and ethnic background in biomedical research and clinical practice. N. Engl. J. Med. 348 (2003) 1170-1175
10. Caetano R. Alcohol-related health disparities and treatment-related epidemiological findings among whites, blacks, and Hispanics in the United States. Alcohol. Clin. Exp. Res. 27 (2003) 1337-1339
11. Council of Economic Advisors for the President's Initiative on Race, 1998. Changing America: Indicators of Social and Economic Well-Being by Race and Hispanic Origin. Washington DC, White House.
12. Chakravarti A. To a future of genetic medicine. Nature 409 (2001) 822-823
13. Chen A.C., LaForge K.S., Ho A., McHugh P.F., Kellogg S., Bell K., Schluger R.P., Leal S.M., and Kreek M.J. Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse. Am. J. Med. Genet. 114 (2002) 429-435
14. Cigler T., LaForge K.S., McHugh P.F., Kapadia S.U., Leal S.M., and Kreek M.J. Novel and previously reported single-nucleotide polymorphisms in the human 5-HT(1B) receptor gene: no association with cocaine or alcohol abuse or dependence. Am. J. Med. Genet. 105 (2001) 489-497
15. Cooper S.P., Burau K., Sweeney A., Robison T., Smith M.A., Symanski E., Colt J.S., Laseter J., and Zahm S.H. Prenatal exposure to pesticides: a feasibility study among migrant and seasonal farmworkers. Am. J. Ind. Med. 40 (2001) 578-585
16. Cooper S.P., Darragh A.R., Vernon S.W., Stallones L., MacNaughton N., Robison T., Hanis C., and Zahm S.H. Ascertainment of pesticide exposures of migrant and seasonal farmworker children: findings from focus groups. Am. J. Ind. Med. 40 (2001) 531-537
17. Costa L., and Bauer L.O. Quantitative electroencephalographic differences associated with alcohol, cocaine, heroin and dual-substance dependence. Drug Alcohol Depend. 46 (1997) 87-93
18. Covington H.E., and Miczek III K.A. Repeated social-defeat stress, cocaine or morphine. Effects on behavioral sensitization and intravenous cocaine self-administration "binges". Psychopharmacology (Berl) 158 (2001) 388-398
19. Cowan W.M., Kopnisky K.L., and Hyman S.E. The human genome project and its impact on psychiatry. Annu. Rev. Neurosci. 25 (2002) 1-50
20. Crabbe J.C. Genetic contributions to addiction. Annu. Rev. Psychol. 53 (2002) 435-462
21. Duffard R., and Evangelista de Duffard A.M. Environmental chemical compounds could induce sensitization to drugs of abuse. Ann. N. Y. Acad. Sci. 965 (2002) 305-313
22. Ehlers C.L., Garcia-Andrade C., Wall T.L., Cloutier D., and Phillips E. Electroencephalographic responses to alcohol challenge in Native American Mission Indians. Biol. Psychiatr. 45 (1999) 776-787
23. Ehlers C.L., Phillips E., and Schuckit M.A. EEG alpha variants and alpha power in Hispanic American and white non-Hispanic American young adults with a family history of alcohol dependence. Alcohol 33 (2004) 99-106
24. Ehlers C.L., Phillips E., Wall T.L., Wilhelmsen K., and Schuckit M.A. EEG alpha and level of response to alcohol in Hispanic- and non-Hispanic-American young adults with a family history of alcoholism. J. Stud. Alcohol. 65 (2004) 301-308
25. Escobar J.I., and Tuason V.B. Antidepressant agents-a cross-cultural study. Psychopharmacol. Bull. 16 (1980) 49-52
26. Evans W.E., and Johnson J.A. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu. Rev. Genom. Hum. Genet. 2 (2001) 9-39
27. Feinn R., Nellissery M., and Kranzler H.R. Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 133 (2005) 79-84
28. Fernandez-Teruel A., Escorihuela R.M., Castellano B., Gonzalez B., and Tobena A. Neonatal handling and environmental enrichment effects on emotionality, novelty/reward seeking, and age-related cognitive and hippocampal impairments: focus on the Roman rat lines. Behav. Genet. 27 (1997) 513-526
29. Fernandez-Teruel A., Driscoll P., Gil L., Aguilar R., Tobena A., and Escorihuela R.M. Enduring effects of environmental enrichment on novelty seeking, saccharin and ethanol intake in two rat lines (RHA/Verh and RLA/Verh) differing in incentive-seeking behavior. Pharmacol. Biochem. Behav. 73 (2002) 225-231
30. Flores G., Fuentes-Afflick E., Barbot O., Carter-Pokras O., Claudio L., Lara M., McLaurin J.A., Pachter L., Gomez F.R., Mendoza F., Valdez R.B., Villarruel A.M., Zambrana R.E., Greenberg R., and Weitzman M. The health of Latino children: urgent priorities, unanswered questions, and a research agenda. JAMA 288 (2002) 82-90
31. Frackiewicz E.J., Sramek J.J., Herrera J.M., Kurtz N.M., and Cutler N.R. Ethnicity and antipsychotic response. Ann. Pharmacother. 31 (1997) 1360-1369
32. Frackiewicz E.J., Herrera J.M., Sramek J.J., Collazo Y., and Lawson W.B. Risperidone in the treatment of Hispanic inpatients with schizophrenia: a pilot study. Psychiatry 65 (2002) 371-374
33. Fumita M., and Innes R.B. In vivo molecular imaging: ligand development and research implications. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2002), Lippencott Williams and Wilkins, Philadephia, PA 411-425
34. Galarza N.J., Diaz R.D., Guzman F., Caballero J.A., and Martinez A.J. The use of naltrexone to treat ambulatory patients with alcohol dependence. Boletin Asociacion Medica de Puerto Rico. 89 (1997) 157-160
35. Gatley S.J., and Volkow N.D. Addiction and imaging of the living human brain. Drug Alcohol Depend. 51 (1998) 97-108
36. Goeders N.E. Stress and cocaine addiction. J. Pharmacol. Exp. Ther. 301 (2002) 785-789
37. Gorelick D.A., Montoya I.D., and Johnson E.O. Sociodemographic representation in published studies of cocaine abuse pharmacotherapy. Drug Alcohol Depend. 49 (1998) 89-93
38. Gralewicz S., Wiaderna D., and Lutz P. Behavioral sensitivity to amphetamine after repeated exposure to an organophosphorous pesticide in the rat. Effect of coexposure to restraint. Int. J. Occup. Med. Environ. Health 15 (2002) 229-238
39. Grassman J.A. Obtaining information about susceptibility from the epidemiological literature. Toxicology 111 (1996) 253-270
40. Hernandez-Valero M.A., Bondy M.L., Spitz M.R., and Zahm S.H. Evaluation of Mexican American migrant farmworker work practices and organochlorine pesticide metabolites. Am. J. Ind. Med. 40 (2001) 554-560
41. Herning R.I. Cognitive event-related potentials in populations at risk for substance abuse. NIDA Res. Monogr. 159 (1996) 161-185
42. Herning R.I., Glover B.J., Koeppl B., Phillips R.L., and London E.D. Cocaine-induced increases in EEG alpha and beta activity: evidence for reduced cortical processing. Neuropsychopharmacology 11 (1994) 1-9
43. Heyne A., and Wolffgramm J. The development of addiction to d-amphetamine in an animal model: same principles as for alcohol and opiate. Psychopharmacology (Berl) 140 (1998) 510-518
44. Human Genome Project, 2006. Minorities, race and genomics. Accessed on June 15, 2005. Available: http://www.ornl.gov/sci/techresources/Human_Genome/elsi/minorities.shtml.
45. Hill S.Y., and Neiswanger K. The value of narrow psychiatric phenotypes and "super" normal controls. In: Blum K., and Noble E.P. (Eds). Handbook of Psychiatric Genetics (1997), CRC Press, Boca Raton, FL 37-46
46. Hill A.L., Roe D.J., Taren D.L., Muramoto M.M., and Leischow S.J. Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample. Nicotine & Tobacco Research. 2 (2000) 247-253
47. Holden C. Race and medicine. Science 302 (2003) 594-596
48. Humphreys K., and Weisner C. Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies. Am. J. Psychiatry. 157 (2000) 588-594
49. Iacono W.G., Lykken D.T., and McGue M. Psychophysiological prediction of substance abuse. NIDA Res. Monogr. 159 (1996) 129-149
50. Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 5 (2005) 6-13
51. Ishiguro H., Arinami T., Saito T., Akazawa S., Enomoto M., Mitushio H., Fujishiro H., Tada K., Akimoto Y., Mifune H., Shioduka S., Hamaguchi H., Toru M., and Shibuya H. Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism. Alcohol. Clin. Exp. Res. 22 (1998) 845-848
52. Javors M.A., Seneviratne C., Roache J.D., Ait-Daoud N., Bergeson S.E., Walss-Bass M.C., Akhtar F.Z., and Johnson B.A. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Prog. Neuropsychopharmacol. Biol. Psychiatr. 29 (2005) 7-13
53. Johnston L.D., O'Malley P.M., and Bachman J.G. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, (NIH Publication no. 02-5105) (2001), National Institute on Drug Abuse, Bethesda, MD
54. Johnston L.D., O'Malley P.M., and Bachman J.G. Monitoring the Future National Survey Results on Drug Use, vol. II: College Students and Adults Ages 19-40 (NIH Publication no. 02-5107) (1975-2001), National Institute on Drug Abuse, Bethesda, MD
55. Jorgenson E., Tang H., Gadde M., Province M., Leppert M., Kardia S., Schork N., Cooper R., Rao D.C., Boerwinkle E., and Risch N. Ethnicity and human genetic linkage maps. Am. J. Hum. Genet. 76 (2005) 276-290
56. Kabbaj M., Norton C.S., Kollack-Walker S., Watson S.J., Robinson T.E., and Akil H. Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior. Psychopharmacology (Berl) 158 (2001) 382-387
57. Konishi T., Calvillo M., Leng A.S., Feng J., Lee T., Lee H., Smith J.L., Sial S.H., Berman N., French S., Eysselein V., Lin K.M., and Wan Y.J. The ADH3*2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican American men. Exp. Mol. Pathol. 74 (2003) 183-189
58. Konishi T., Smith J.L., Lin K.M., and Wan Y.J. Influence of genetic admixture on polymorphisms of alcohol-metabolizing enzymes: analyses of mutations on the CYP2E1, ADH2, ADH3 and ALDH2 genes in a Mexican-American population living in the Los Angeles area. Alcohol Alcohol. 38 (2003) 93-94
59. Konishi T., Calvillo M., Leng A.S., Lin K.M., and Wan Y.J. Polymorphisms of the dopamine D2 receptor, serotonin transporter, and GABA(A) receptor beta(3) subunit genes and alcoholism in Mexican-Americans. Alcohol 32 (2004) 45-52
60. Konishi T., Luo H.R., Calvillo M., Mayo M.S., Lin K.M., and Wan Y.J. ADH1B*1, ADH1C*2, DRD2 (-141C Ins), and 5-HTTLPR are associated with alcoholism in Mexican American men living in Los Angeles. Alcohol. Clin. Exp. Res. 28 (2004) 1145-1152
61. Kopnisky K.L., and Hyman S.E. Molecular and cellular biology of addiction. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2002), Lippencott Williams and Wilkins, Philadephia, PA 1367-1379
62. Kosten T.R., and Rayford B.S. Effects of ethnicity on low-dose opiate stablization. J. Subst. Abuse Treat. 12 (1995) 111-116
63. Krause N., and Goldenhar L.M. Acculturation and psychological distress in three groups of elderly Hispanics. J. Gerontol. 47 (1992) S279-S288
64. Kreek M.J., Nielsen D.A., and LaForge K.S. Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med. 5 (2004) 85-108
65. Kreek M.J., Bart G., Lilly C., LaForge K.S., and Nielsen D.A. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol. Rev. 57 (2005) 1-26
66. LaForge K.S., Yuferov V., and Kreek M.J. Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur. J. Pharmacol. 410 (2000) 249-268
67. Lamba V., Lamba J., Yasuda K., Strom S., Davila J., Hancock M.L., Fackenthal J.D., Rogan P.K., Ring B., Wrighton S.A., and Schuetz E.G. Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J. Pharmacol. Exp. Ther. 307 (2003) 906-922
68. Lichtermann D., Franke P., Maier W., and Rao M.L. Pharmacogenomics and addiction to opiates. Eur. J. Pharmacol. 410 (2000) 269-279
69. Lutz P., Tomas T., Gralewicz S., and Nowakowska E. Long-term effects of acute exposure to chlorphenvinphos on behavioural responsiveness to amphetamine and scopolamine in rats. Int. J. Occup. Med. Environ. Health 13 (2000) 215-222
70. Madrid G.A., MacMurray J., Lee J.W., Anderson B.A., and Comings D.E. Stress as a mediating factor in the association between the DRD2 Taq I polymorphism and alcoholism. Alcohol 23 (2001) 117-122
71. Mann R.E., Smart R.G., and Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res. Health 27 (2003) 209-219
72. Marcos L.R., and Cancro R. Pharmacotherapy of Hispanic depressed patients: clinical observations. Am. J. Psychother. 36 (1982) 505-512
73. Marin H., and Escobar J.I. Special issues in the psychopharmacological management of Hispanic Americans. Psychopharmacol. Bull. 35 (2001) 197-212
74. Mayer P., and Hollt V. Allelic and somatic variations in the endogenous opioid system of humans. Pharmacol. Ther. 91 (2001) 167-177
75. McInnes L.A., and Freimer N.B. Using human genomics to advance neuropsychopharmacology. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2002), Lippencott Williams and Wilkins, Philadephia, PA 231-240
76. Mendoza R., Wan Y.-J., Poland R.E., Smith M., Zheng Y., Berman N., and Lin K.-M. CYP2D6 polymorphism in a Mexican American population. Clin. Pharmacol. Ther. 70 (2001) 552-560
77. Merikangas K.R., Chakravarti A., Moldin S.O., Araj H., Blangero J., Burmeister M., Crabbe J.C., and Depaulo J.R. Future of genetics of mood disorders research. Biol. Psychiatr. 52 (2002) 457-477
78. Miller D.K., Palme K.M., Najvar S.A., Caudill S.D., and Nation J.R. Chronic cadmium exposure attenuates conditioned place preference produced by cocaine and other drugs. Pharmacol. Biochem. Behav. 64 (1999) 15-20
79. Miller D.K., Nation J.R., and Bratton G.R. Perinatal exposure to lead attenuates the conditioned reinforcing properties of cocaine in male rats. Pharmacol. Biochem. Behav. 67 (2000) 111-119
80. Morgan D., Grant K.A., Gage H.D., Mach R.H., Kaplan J.R., Prioleau O., Nader S.H., Buchheimer N., Ehrenkaufer R.L., and Nader M. A Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat. Neurosci. 5 (2002) 169-174
81. Nation J.R., Miller D.K., and Livermore C.L. Chronic exposure to cadmium attenuates behavioral sensitization to morphine. Psychopharmacology (Berl). 131 (1997) 248-254
82. Nation J.R., Miller D.K., and Bratton G.R. Dietary cadmium exposure alters characteristics of training, substitution, and tolerance when morphine is used as a discriminative stimulus. Neurotoxicology. 21 (2000) 553-567
83. Nation J.R., Cardon A.L., Heard H.M., Valles R., and Bratton G.R. Perinatal lead exposure and relapse to drug-seeking behavior in the rat: a cocaine reinstatement study. Psychopharmacology. (2003) (Berl)
84. Nestler E.J., and Landsman D. Learning about addiction from the genome. Nature 409 (2001) 834-835
85. National Institute on Drug Abuse, 2000. Strategic Plan on Reducing Health Disparities, 2003.
86. Noble E.P. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am. J. Med. Genet. 116 (2003) 103-125
87. Ozdemir V., Basile V.S., Masellis M., Muglia P., and Kennedy J.L. Pharmacogenomics and personalized therapeutics in psychiatry. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2002), Lippencott Williams and Wilkins, Philadephia, PA 495-524
88. Parkinson A., Mudra D.R., Johnson C., Dwyer A., and Carroll K.M. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol. Appl. Pharmacol. 199 (2004) 193-209
89. Parsian A., Cloninger C.R., and Zhang Z.H. Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism. Am. J. Med. Genet. 96 (2000) 407-411
90. Patrinos A. 'Race' and the human genome: sponsor's foreward to Nature Genetics Supplement. Nat. Genet. 36 (2004) S1-S2
91. Phillips R.L., Herning R., and London E.D. Morphine effects on the spontaneous electroencephalogram in polydrug abusers: correlations with subjective self-reports. Neuropsychopharmacology 10 (1994) 171-181
92. Piazza P.V., and LeMoal M.L. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 36 (1996) 359-378
93. Piazza P.V., and LeMoal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19 (1998) 67-74
94. Piazza P.V., Deminiere J.M., LeMoal M., and Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514 (1990) 22-26
95. Piazza P.V., Maccari S., Deminiere J.M., LeMoal M., Mormede P., and Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2088-2092
96. Prichep L.S., Alper K.R., Sverdlov L., Kowalik S.C., John E.R., Merkin H., Tom M.L., Howard B., and Rosenthal M.S. Outcome related electrophysiological subtypes of cocaine dependence. Clin. Electroencephalogr. 33 (2002) 8-20
97. Raucy J.L., Schultz E.D., Kearins M.C., Arora S., Johnston D.E., Omdahl J.L., Eckmann L., and Carpenter S.P. CYP2E1 expression in human lymphocytes from various ethnic populations. Alcohol. Clin. Exp. Res. 23 (1999) 1868-1874
98. Risch N.J. Searching for genetic determinants in the new millennium. Nature 405 (2000) 847-856
99. Risch N., Burchard E., Ziv E., and Tang H. Categorization of humans in biomedical research: genes, race and disease. Genome Biol. 3 (2002) (comment 2007)
100. Russo D., Purohit V., Foudin L., and Salin M. Workshop on alcohol use and health disparities 2002: a call to arms. Alcohol 32 (2004) 37-43
101. Substance Abuse and Mental Health Services Administration, 2001. National Household Survey on Drug Abuse (NHSDA), 2003.
102. Sander T., Ladehoff M., Samochowiec J., Finckh U., Rommelspacher H., and Schmidt L.G. Lack of an allelic association between polymorphisms of the dopamine D2 receptor gene and alcohol dependence in the German population. Alcohol. Clin. Exp. Res. 23 (1999) 578-581
103. Schuckit M.A. Vulnerability factors for alcoholism. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2002), Lippencott Williams and Wilkins, Philadephia, PA 1399-1411
104. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl) 158 (2001) 343-359
105. Sjoquist B., Johnson H.A., Neri A., and Linden S. The influence of thiamine deficiency and ethanol on rat brain catecholamines. Drug Alcohol Depend. 22 (1988) 187-193
106. In: Smedley B.D., Stith A.Y., and Nelson A.R. (Eds). Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (2003), National Academies Press, Washington, DC
107. Smith J.K., Neill J.C., and Costall B. Post-weaning housing conditions influence the behavioural effects of cocaine and d-amphetamine. Psychopharmacology (Berl) 131 (1997) 23-33
108. Smith J.K., Neill J.C., and Costall B. The influence of post-weaning housing conditions on drug-induced conditioned taste aversion. Pharmacol. Biochem. Behav. 59 (1998) 379-386
109. Sorg B.A., and Newlin D.B. Sensitization as a mechanism for multiple chemical sensitivity: relationship to evolutionary theory. Scand. J. Psychol. 43 (2002) 161-167
110. Sorg B.A., Tschirgi M.L., Swindell S., Chen L., and Fang J. Repeated formaldehyde effects in an animal model for multiple chemical sensitivity. Ann. N. Y. Acad. Sci. 933 (2001) 57-67
111. Social Science Research Council, 2006. Is race "real"? A web forum organized by the Social Science Research Council. Accessed on June 15, 2005. Available: http://raceandgenomics.ssrc.org/.
112. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J. Psychiatr. Neurosci. 25 (2000) 125-136
113. Stewart S.H. Racial and ethnic differences in alcohol-associated aspartate aminotransferase and gamma-glutamyltransferase elevation. Arch. Intern. Med. 162 (2002) 2236-2239
114. Tang H., Quertermous T., Rodriguez B., Kardia S.L., Zhu X., Brown A., Pankow J.S., Province M.A., Hunt S.C., Boerwinkle E., Schork N.J., and Risch N.J. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am. J. Hum. Genet. 76 (2005) 268-275
115. Taylor R.E. Pharmacological and cultural considerations in alcohol treatment clinical trials: issues in clinical research related to race and ethnicity. Alcohol. Clin. Exp. Res. 27 (2003) 1345-1348
116. Thompson B., Coronado G.D., Grossman J.E., Puschel K., Solomon C.C., Islas I., Curl C.L., Shirai J.H., Kissel J.C., and Fenske R.A. Pesticide take-home pathway among children of agricultural workers: study design, methods, and baseline findings. J. Occup. Environ. Med. 45 (2003) 42-53
117. Tidey J.W., and Miczek K.A. Acquisition of cocaine self-administration after social stress: role of accumbens dopamine. Psychopharmacology (Berl) 130 (1997) 203-212
118. Town T., Schinka J., Tan J., and Mullan M. The opioid receptor system and alcoholism: a genetic perspective. Eur. J. Pharmacol. 410 (2000) 243-248
119. Trujillo K.A., Castañeda E., Martinez D., Thompson K., and Gonzalez G. Neuroscience research on Hispanic drug abuse. In: Amaro H., and Cortes D. (Eds). National Strategic Plan on Hispanic Drug Abuse Research (2004), National Hispanic Science Network
120. Uhl G.R., Liu Q.-R., Walther D., Hess J., and Naiman D. Polysubstance abuse-vulnerability genes: genome scans for association, using 1004 subjects and 1494 single-nucleotide polymorphisms. Am. J. Hum. Genet. 69 (2001) 1290-1300
121. United States General Accounting Office. Pesticides: Improvements Needed to Ensure the Safety of Farmworkers and their Children (2000), General Accounting Office, Washington, DC
122. Volkow N.D., and Fowler J.S. Application of imaging technologies in the investigation of drug addiction. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2002), Lippencott Williams and Wilkins, Philadephia, PA 1475-1490
123. Wan Y.J., Poland R.E., and Lin K.M. Genetic polymorphism of CYP2E1, ADH2, and ALDH2 in Mexican-Americans. Genet. Test. 2 (1998) 79-83
124. Weber W.W. Populations and genetic polymorphisms. Mol. Diagn. 4 (1999) 299-307
125. Wijsman E.M. Association vs. linkage analysis in mental disorders. In: Blum K., and Noble E.P. (Eds). Handbook of Psychiatric Genetics (1997), CRC Press, Boca Raton, FL 7-23
126. Wolffgramm J. An ethopharmacological approach to the development of drug addiction. Neurosci. Biobehav. Rev. 15 (1991) 515-519
127. Wolffgramm J., and Heyne A. Social behavior, dominance, and social deprivation of rats determine drug choice. Pharmacol. Biochem. Behav. 38 (1991) 389-399
128. Wolffgramm J., Galli G., Thimm F., and Heyne A. Animal models of addiction: models for therapeutic strategies?. J. Neural Transm. 107 (2000) 649-668
129. Wu X., Hudmon K.S., Detry M.A., Chamberlain R.M., and Spitz M.R. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 1021-1026
130. Xie H.G., Kim R.B., Wood A.J., and Stein C.M. Molecular basis of ethnic differences in drug disposition and response. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 815-850
131. Yuferov V., Fussell D., LaForge K.S., Nielsen D.A., Gordon D., Ho A., Leal S.M., Ott J., and Kreek M.J. Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics 14 (2004) 793-804